These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 8036134
21. Morphometric study of the bone marrow in polycythemia vera following interferon-alpha therapy. Franco V, Florena AM, Aragona F, Campesi G. Pathol Res Pract; 1993 Feb; 189(1):52-7. PubMed ID: 8516217 [Abstract] [Full Text] [Related]
22. The bone marrow in myeloproliferative and dysmyelopoietic syndromes. Wolf BC, Neiman RS. Hematol Oncol Clin North Am; 1988 Dec; 2(4):669-94. PubMed ID: 3065324 [Abstract] [Full Text] [Related]
23. Bone marrow biopsy in polycythaemia vera. Krasznai G, Nagy G, Rácz M. Acta Med Acad Sci Hung; 1969 Dec; 26(4):309-16. PubMed ID: 5380803 [No Abstract] [Full Text] [Related]
24. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients. Thiele J, Kvasnicka HM, Muehlhausen K, Walter S, Zankovich R, Diehl V. Pathol Res Pract; 2001 Dec; 197(2):77-84. PubMed ID: 11261821 [Abstract] [Full Text] [Related]
25. [Polycythemia vera and pregnancy: difficulties for diagnosis and treatment]. Deruelle P, Bouhassoun J, Trillot N, Jude B, Ducloy AS, Subtil D. Gynecol Obstet Fertil; 2005 May; 33(5):331-7. PubMed ID: 15878688 [Abstract] [Full Text] [Related]
26. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis. Mossuz P, Girodon F, Donnard M, Latger-Cannard V, Dobo I, Boiret N, Lecron JC, Binquet C, Barro C, Hermouet S, Praloran V. Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203 [Abstract] [Full Text] [Related]
27. Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations. Barraco D, Cerquozzi S, Hanson CA, Ketterling RP, Pardanani A, Gangat N, Tefferi A. Blood Cancer J; 2017 Mar 10; 7(3):e538. PubMed ID: 28282034 [Abstract] [Full Text] [Related]
28. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases]. Sánchez Fayos J, Prieto E, Román A, Soto de Ozaeta C, Nevado I, Richart A, Chica E, Loscertales J, Calabuig T, Benítez J, Outeiriño J. Sangre (Barc); 1996 Dec 10; 41(6):447-57. PubMed ID: 9148422 [Abstract] [Full Text] [Related]
29. Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Randi ML, Bertozzi I, Marino F, Vannucchi AM, Pieri L, Rotunno G, Gisslinger H, Gisslinger B, Müllauer L, Finazzi G, Carobbio A, Gianatti A, Ruggeri M, Nichele I, D'Amore E, Rambaldi A, Tefferi A. Blood; 2012 Mar 08; 119(10):2239-41. PubMed ID: 22246040 [Abstract] [Full Text] [Related]
30. Prognostic parameters in polycythaemia vera rubra. Correlations of clinical and histomorphological features in 60 patients. Zankovich R, Thiele J, Fiessler WD, Fischer R, Diehl V. Med Klin (Munich); 1987 Dec 11; 82(25-26):889-94, 927. PubMed ID: 3437853 [No Abstract] [Full Text] [Related]
31. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera. Kvasnicka HM, Thiele J. Semin Thromb Hemost; 2006 Jun 11; 32(4 Pt 2):362-71. PubMed ID: 16810612 [Abstract] [Full Text] [Related]
32. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients. Thiele J, Kvasnicka HM. Ann Hematol; 2003 Mar 11; 82(3):148-52. PubMed ID: 12634946 [Abstract] [Full Text] [Related]
33. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome]. Raya Sánchez JM, Hernández Nieto L, Brito Barroso ML, Hernández García MT. Med Clin (Barc); 1994 Mar 19; 102(10):380-2. PubMed ID: 8182985 [Abstract] [Full Text] [Related]
34. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W. Semin Thromb Hemost; 2006 Apr 19; 32(3):174-207. PubMed ID: 16673274 [Abstract] [Full Text] [Related]
36. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression. Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K. Eur J Haematol; 2004 Jun 19; 72(6):410-5. PubMed ID: 15128419 [Abstract] [Full Text] [Related]
37. Transplant decision-making strategies in the myeloproliferative disorders. Fruchtman SM. Semin Hematol; 2003 Jan 19; 40(1 Suppl 1):30-3. PubMed ID: 12682880 [Abstract] [Full Text] [Related]
38. [Quantitative study of the medullar fibrosis in 84 cases of idiopathic myeloid splenomegaly (author's transl)]. Dumont J, d'Athis P, Atken N, Binet JL, Ripault J, Worhauer W, Bernard J. Pathol Biol (Paris); 1979 Apr 19; 27(4):221-6. PubMed ID: 379761 [Abstract] [Full Text] [Related]
39. [The value of the initial bone biopsy in chronic myeloproliferative syndromes. Review of 80 cases]. Ortuño F, Zuazu I, Bordes R, Brunet S, Puig J, Ayats R. Sangre (Barc); 1989 Apr 19; 34(2):117-25. PubMed ID: 2667169 [Abstract] [Full Text] [Related]
40. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV). Thiele J, Kvasnicka HM. Histol Histopathol; 2005 Jan 19; 20(1):317-28. PubMed ID: 15578448 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]